BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin YL, Wang YL, Fu XL, Li WP, Wang YH, Ma JG. Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer. Oncotarget 2016;7:28384-92. [PMID: 27070091 DOI: 10.18632/oncotarget.8635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou X, Padanad MS, Evers BM, Smith B, Novaresi N, Suresh S, Richardson JA, Stein E, Zhu J, Hammer RE, O'Donnell KA. Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function. Mol Cancer Res 2019;17:594-603. [PMID: 30409919 DOI: 10.1158/1541-7786.MCR-18-0739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Dutra TTB, Bezerra TMM, Luna ECM, Carvalho FSR, Chaves FN, Barros Silva PG, Costa FWG, Pereira KMA. Do Protocadherins Show Prognostic Value in the Carcinogenesis of Human Malignant Neoplasms? Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2020;21:3677-88. [PMID: 33369468 DOI: 10.31557/APJCP.2020.21.12.3677] [Reference Citation Analysis]
3 van der Weyden L, Offord V, Turner G, Swiatkowska A, Speak AO, Adams DJ. Membrane protein regulators of melanoma pulmonary colonisation identified using a CRISPRa screen and spontaneous metastasis assay in mice. G3 (Bethesda) 2021:jkab157. [PMID: 33963380 DOI: 10.1093/g3journal/jkab157] [Reference Citation Analysis]
4 Okuno K, Akiyama Y, Shimada S, Nakagawa M, Tanioka T, Inokuchi M, Yamaoka S, Kojima K, Tanaka S. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression. Carcinogenesis 2019;40:15-26. [PMID: 30508037 DOI: 10.1093/carcin/bgy147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chen HF, Ma RR, He JY, Zhang H, Liu XL, Guo XY, Gao P. Protocadherin 7 inhibits cell migration and invasion through E-cadherin in gastric cancer. Tumour Biol 2017;39:1010428317697551. [PMID: 28381163 DOI: 10.1177/1010428317697551] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
6 Xu S, Wu X, Tao Z, Li H, Fan C, Chen S, Guo J, Ning Y, Hu X. Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells. Genes Genomics 2020;42:299-307. [PMID: 31872382 DOI: 10.1007/s13258-019-00903-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang S, Fu X. The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer. Cancer Manag Res 2021;13:3841-7. [PMID: 34012292 DOI: 10.2147/CMAR.S298072] [Reference Citation Analysis]
8 Colás-Algora N, Millán J. How many cadherins do human endothelial cells express? Cell Mol Life Sci 2019;76:1299-317. [PMID: 30552441 DOI: 10.1007/s00018-018-2991-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Shishodia G, Koul S, Koul HK. Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling. Prostate 2019;79:1739-51. [DOI: 10.1002/pros.23898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]